RESPONSE RATES TO SINGLE-AGENT CARFILZOMIB IN PATIENTS DOUBLE REFRACTORY OR INTOLERANT TO BORTEZOMIB AND IMMUNOMODULATORS IN TRIAL PX-171-003-A1

HAEMATOLOGICA(2012)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要